Fibrocor Therapeutics strengthens its clinical strategy with the appointment of four world-leading nephrology and genetics experts to its Clinical Advisory Board (CAB), reinforcing its scientific ...
Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients80% CR and ...
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide four NHS trusts with a single enterprise imaging solution delivered as a cloud service, Sectra One Cloud.
Scarcell Therapeutics, an innovator in cell therapies to treat chronic degenerative inflammatory diseases, today announced the world's first patients treated with its Allogenic Gingival Fibroblast ...
Transcript: Post Next: Future of Cancer ...
UCSF’s Program in Craniofacial Biology (PCB) brings together researchers to study the cellular and molecular mechanisms ...
Codetta Bio™, a leading innovator in multi-omic solutions that integrate ultrasensitive protein quantitation with simultaneous analysis of nucleic acids (RNA and DNA), ...
Roundup was first brought to market by Monsanto in 1974. Its active ingredient, glyphosate, had been rediscovered by chemists Phil Hamm and John Franz four years prior – it had first been synthesized ...
This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...
A collaborative approach to cancer research and innovation has placed the island of Ireland above many of its European ...
The IMD Startup Competition has selected 13 startups to collaborate with participants in the Executive MBA. The competition is an annual event that highlights high-potential Swiss ventures, giving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback